Cargando…

Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial

OBJECTIVE: The objective of this study is to evaluate if gonadotropin-releasing hormone agonist (GnRHa) trigger is a better alternative to human chorionic gonadotropin (hCG) in polycystic ovary syndrome (PCOS) of Indian origin undergoing in vitro fertilization (IVF) cycles with GnRH antagonist for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishna, Deepika, Dhoble, Snehal, Praneesh, Gautham, Rathore, Suvarna, Upadhaya, Amit, Rao, Kamini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070398/ https://www.ncbi.nlm.nih.gov/pubmed/27803584 http://dx.doi.org/10.4103/0974-1208.192056

Ejemplares similares

Repeat Dose of Gonadotropin-releasing Hormone Agonist Trigger in Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization Cycles Provides a Better Cycle Outcome - A proof-of-concept Study
por: Deepika, Krishna, et al.
Publicado: (2017)

HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes
por: Deepika, Krishna, et al.
Publicado: (2021)

Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles
por: Deepika, Krishna, et al.
Publicado: (2018)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Human Chorionic Gonadotropin Priming Does Not Improve Pregnancy Outcomes of PCOS-IVM Cycles
por: Lin, Yihua, et al.
Publicado: (2020)

Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)
por: de Oliveira, Sofia Andrade, et al.
Publicado: (2016)

Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats
por: TUNGMAHASUK, Doungrut, et al.
Publicado: (2017)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
por: Halim, Binarwan, et al.
Publicado: (2022)

Experimental Production of Gynecomastia with Chorionic Gonadotropin
por: Klatskin, Gerald, et al.
Publicado: (1952)

Chorionic gonadotropin and uterine dialogue in the primate
por: Cameo, Paula, et al.
Publicado: (2004)

IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN CHORIONIC GONADOTROPIN
por: Midgley, A. R., et al.
Publicado: (1962)

Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022)

Fertility Rates of Ewes Treated with Medroxyprogesterone and Injected with Equine Chorionic Gonadotropin plus Human Chorionic Gonadotropin in Anoestrous Season
por: Santos, I. W., et al.
Publicado: (2010)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
por: Liu, ShuQin, et al.
Publicado: (2017)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017)

Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review
por: Vyrides, Andreas A, et al.
Publicado: (2022)

Human Chorionic Gonadotropin: The Pregnancy Hormone and More
por: Theofanakis, Charalampos, et al.
Publicado: (2017)

Human Chorionic Gonadotropin and Early Embryogenesis: Review
por: d’Hauterive, Sophie Perrier, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Production of Mare Chorionic Girdle Organoids That Secrete Equine Chorionic Gonadotropin
por: Thompson, Riley E., et al.
Publicado: (2023)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve
por: Lin, Ming-Huei, et al.
Publicado: (2019)

Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
por: Karacan, Meric, et al.
Publicado: (2017)

Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
por: Mahajan, Nalini, et al.
Publicado: (2016)

New discoveries on the biology and detection of human chorionic gonadotropin
por: Cole, Laurence A
Publicado: (2009)

Management of Nonpregnant Women with Elevated Human Chorionic Gonadotropin
por: Schmid, Bernd C., et al.
Publicado: (2013)

Endometrial carcinoma with ectopic human chorionic gonadotropin expression
por: Lee, Regina, et al.
Publicado: (2015)

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses
por: De, Alpana, et al.
Publicado: (2018)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles
por: Albeitawi, Soha, et al.
Publicado: (2022)

Independent value of serum β-human chorionic gonadotropin in predicting early pregnancy loss risks in IVF/ICSI cycles
por: Wang, Liyan, et al.
Publicado: (2022)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Total human chorionic gonadotropin is a more suitable diagnostic marker of gestational trophoblastic diseases than the free β-subunit of human chorionic gonadotropin
por: Usui, Hirokazu, et al.
Publicado: (2023)

A borderline form of empty follicle syndrome treated with a double-trigger of gonadotropin-releasing hormone agonist and human chorionic gonadotropin: A case report
por: Song, Jingyan, et al.
Publicado: (2019)

Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT
por: Taheripanah, Robabeh, et al.
Publicado: (2017)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology
por: Pratap, Deepika, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k1nrqsfjtg0tib9ahedje5gqn9